Printer Friendly
The Free Library
14,551,645 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Africa faces new meningitis threat. (Emerging Infections).


A previously rare, vaccine-resistant strain of a deadly bacterium caused an epidemic of meningitis last year in western Africa and seems to have spread around the world, researchers report.

Three years ago, people from more than a dozen countries in Africa, Asia, Europe, and North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere.  became infected with the W-135 strain of Neisseria meningitidis Neisseria men·in·git·i·dis
n.
The bacteria that is the causative agent of cerebrospinal meningitis; meningococcus.


Neisseria meningitidis 
 after Muslim pilgrims unknowingly carried it home from the annual Hajj hajj (häj), the pilgrimage to Mecca, Saudi Arabia, one of the five basic requirements (arkan or "pillars") of Islam. Its annual observance corresponds to the major holy day id al-adha,  in Mecca, Saudi Arabia.

Seasonal outbreaks of other strains of N. meningitidis often strike Africa's so-called meningitis belt meningitis belt A popular term for a region of sub-Saharan Africa where epidemics of group A meningococcal infection occur in cycles of
± 10 yrs
, which stretches from Senegal to Ethiopia. Anticipating that W-135 might cause an outbreak, Joshua Jones of the CDC See Control Data, century date change and Back Orifice.

CDC - Control Data Corporation
 in Atlanta and his colleagues closely monitored three meningitisbelt nations for 6 months last year. Sure enough, they detected an outbreak of the rare strain as it moved through Burkina Faso.

A relatively inexpensive vaccine can stop outbreaks of the two most common strains of N. meningitidis. The emerging strain, which can be blocked only by a much pricier vaccine, could hamper meningitis-control efforts in Africa, says Jones. Public health officials are now working with vaccine manufacturers to develop a cheaper vaccine that's effective against W-135.--B.H.
COPYRIGHT 2003 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Science News
Article Type:Brief Article
Geographic Code:60AFR
Date:Apr 19, 2003
Words:190
Previous Article:Vaccine didn't cause heart deaths. (Vaccine Safety).(Brief Article)
Next Article:Transfusions and transplants spread West Nile virus. (Biomedicine).(Brief Article)
Topics:



Related Articles
Cooperation halts meningitis outbreak; leaves positive public perception.(Special Report)
Atypical Chryseobacterium meningosepticum and Meningitis and Sepsis in Newborns and the Immunocompromised, Taiwan.
First epidemic of echovirus 16 meningitis in Cuba. (Dispatches).
Recent increase in meningitis caused by Neisseria meningitidis serogroups A and W135, Yaounde, Cameroon. (Dispatches).
Clonal groupings in serogroup X Neisseria meningitidis. (Research).
Serogroup A Neisseria meningitidis outside meningitis belt in Southwest Cameroon.(Letters)
Isolation of Enterobacter sakazakii from Midgut of Stomoxys calcitrans.(Letters)
Otogenic Fusobacterium meningitis, sepsis, and mastoiditis in an adolescent.(Case Report)
Japanese encephalitis virus in meningitis patients, Japan.(Dispatches)
Toscana virus and acute meningitis, France.(LETTERS)(Letter to the Editor)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles